View Older Stories View More Recent Stories

Jun 5, 2017 06:15AM AstraZeneca (AZN) Presents Data on LYNPARZA (olaparib) Significantly Reduces the Risk of Disease Worsening or Death in Patients at ASCO Meetings
Jun 4, 2017 07:35AM LYNPARZA™ (olaparib) Significantly Reduces the Risk of Disease Worsening or Death in Patients with BRCA-Mutated Metastatic Breast Cancer
May 26, 2017 08:45AM AstraZeneca (AZN) Delivers New Data on Cancer Medicines at ASCO
May 26, 2017 08:43AM AstraZeneca Delivers New Data on Expanding Portfolio of Cancer Medicines at 2017 American Society of Clinical Oncology (ASCO) Annual Meeting
May 25, 2017 05:30PM AstraZeneca Initiates Voluntary Nationwide Recall of One Lot of BRILINTA 90mg Professional Sample Bottles Due to Report of Another Medicine in One Bottle from That Lot
May 23, 2017 07:13AM AstraZeneca (AZN) Announces BYDUREON EXSCEL Trial Meets Primary Safety Objective in Type-2 Diabetes Patients with Rage of CV Risk
May 23, 2017 07:05AM BYDUREON EXSCEL Trial Meets Primary Safety Objective in Type-2 Diabetes Patients at Wide Range of Cardiovascular Risk
May 22, 2017 02:37PM AstraZeneca (AZN) Says Results from Phase III ZONDA Trial Presented at ATS, Published in NEJM
May 22, 2017 02:35PM Phase III ZONDA Trial for benralizumab Shows Ability to Reduce Oral Steroid Use in Severe Asthma Patients
May 3, 2017 07:11AM Pieris Pharma (PIRS), AstraZeneca (AZN) Announced Pact to Develop and Commercialize Anticalin-Based Inhaled Treatments for Respiratory Diseases
May 1, 2017 02:28PM AstraZeneca (AZN) Confirms IMFINZI Receives FDA Accelerated Approval for Previously Treated Patients with Advanced Bladder Cancer
May 1, 2017 02:23PM AstraZeneca’s IMFINZI™ (durvalumab) Receives US FDA Accelerated Approval for Previously Treated Patients with Advanced Bladder Cancer
May 1, 2017 02:20PM AstraZeneca's Imfinzi (durvalumab) Receives US FDA Accelerated Approval for Previously Treated Patients With Advanced Bladder Cancer
Mar 31, 2017 07:00AM TAGRISSO® (osimertinib) Receives US FDA Full Approval
Mar 28, 2017 09:05AM AstraZeneca (AZN) Announces New Data Demonstrate RSV Immunoprophylaxis With SYNAGIS® (palivizumab) May Result in Reduced Overall Costs
Mar 28, 2017 09:00AM New Data Demonstrate RSV Immunoprophylaxis With SYNAGIS® (palivizumab) May Result in Reduced Overall Costs in Preterm Infants Born at 29-32 wGA Who Are Less Than Three Months of Age
Mar 28, 2017 07:05AM AstraZeneca (AZN) Says FDA Accepted NDA for LYNPARZA
Mar 28, 2017 07:00AM AstraZeneca Shares Progress on LYNPARZA™ (olaparib) Tablets in the US
Mar 20, 2017 05:53AM AstraZeneca (AZN) CVD-REAL Study Shows SGLT-2 Inhibitors Significantly Reduced Hospitalizations for Heart Failure and Death Versus Other Type-2 Diabetes Medication
Mar 19, 2017 02:05PM AstraZeneca’s CVD-REAL Study Shows SGLT-2 Inhibitors Significantly Reduced Hospitalizations for Heart Failure and Death versus Other Type-2 Diabetes Medicines
Mar 14, 2017 02:33PM AstraZeneca (AZN) Reports LYNPARZA Phase III SOLO-2 Met Primary Endpoint in Relapsed Ovarian Cancer Patients
Mar 14, 2017 02:32PM LYNPARZA™ (olaparib) Phase III SOLO-2 Data Demonstrated Progression-Free Survival Benefit in BRCA-Mutated Ovarian Cancer as Maintenance Therapy
Feb 28, 2017 05:49AM AstraZeneca (AZN) Announces FDA Approval for Once-Daily QTERN for Type-2 Diabetes
Feb 28, 2017 02:10AM FDA Approves Once-Daily QTERN® (Dapagliflozin and Saxagliptin) Tablets for Adults with Type-2 Diabetes
Feb 17, 2017 07:08AM AstraZeneca (AZN) Says LYNPARZA Met Primary Endpoint in Phase III Trial in BRCA-Mutated Metastatic Breast Cancer
Feb 17, 2017 07:00AM LYNPARZA™ (olaparib) Meets Primary Endpoint in Phase III Trial in BRCA-Mutated Metastatic Breast Cancer
Feb 16, 2017 07:00AM Valeant Receives FDA Approval Of SILIQ™ (Brodalumab) For Moderate-To-Severe Plaque Psoriasis
Dec 23, 2016 06:21AM Pfizer (PFE) Completes Acquisition of AstraZeneca's (AZN) Small Molecule Anti-Infective Business
Dec 8, 2016 08:32AM AstraZeneca (AZN) Offers pre-Specificed Subgroup Analysis of FALCON Trial; PFS Seen as Largely Consistent
Dec 8, 2016 08:30AM AstraZeneca Announces Subgroup Analysis from FALCON Trial Comparing FASLODEX® (fulvestrant) to ARIMIDEX® (anastrozole)
Dec 6, 2016 07:00AM TAGRISSO® (osimertinib) Demonstrates Superiority over Chemotherapy in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer
Dec 5, 2016 12:32PM AstraZeneca (AZN), Acerta Announce Prelim. Acalabrutinib Phase 1/2 Data in CLL; Median PFS Not Yet Met
Dec 5, 2016 12:21PM Early Data Demonstrate Clinical Activity of Acalabrutinib in Difficult-to-Treat Chronic Lymphocytic Leukemia
Nov 11, 2016 08:01AM AstraZeneca (AZN) Announces Significant Results from SYMBICORT Phase 3 in Pediatric Asthma Patients
Nov 11, 2016 08:00AM AstraZeneca Announces Study Results Show SYMBICORT Improves Lung Function in Pediatric Asthma Patients
Oct 28, 2016 08:11AM AstraZeneca (AZN) Announces Data from Second-Season SENTINEL1 Study; Says Results Similar to Prior Season
Oct 28, 2016 08:00AM New Data Shows Frequent ICU Admissions from Severe RSV Disease among Preterm Infants in the First Three Months of Life
Oct 26, 2016 07:01AM AstraZeneca (AZN) Announces Significant PFS Data from LYNPARZA Phase III SOLO-2
Oct 26, 2016 07:00AM LYNPARZATM (olaparib) Phase III SOLO-2 Trial Shows Significant Progression-Free Survival Benefit
Oct 14, 2016 08:30AM Cancer Immunotherapy ETF Celebrates One-Year Anniversary
Aug 24, 2016 06:05AM Pfizer (PFE) Enters Agreement to Acquire AstraZeneca's (AZN) Small Molecule Anti-Infective Business in ~$1.58B Deal
Jun 14, 2016 08:00AM AstraZeneca Introduces AZhelps, an Innovative Savings and Support Program to Help Patients with Their Medicines
Jun 3, 2016 06:25AM Ironwood Pharma (IRWD) Announces Closure of Lesinurad Transaction with AstraZeneca (AZN)
May 27, 2016 03:57PM Top 10 News for 5/23 - 5/27: Computer Sciences to Acquire Key Enterprise Asset; Bayer Makes Run at Monsanto; Twitter has 'Character' Change
Mar 29, 2016 07:17AM Advaxis (ADXS) Announces Completion of First Dose-Escalation for AXAL + Durvalumab Combo in HPV-Associated Cancers
Dec 7, 2015 07:32AM Celgene (CELG), AstraZeneca (AZN) Initiative Durvalumab FUSION Program in Hematologic Disorders
Dec 7, 2015 07:30AM Celgene in Collaboration with Astrazeneca Announce Initiation of Fusion Clinical Development Program in Immuno-Oncology
Nov 6, 2015 10:02AM Notable Mergers and Acquisitions 11/6: (BABA)/(YOKU) (AZN)/(ZSPH) (FNGN) (DIOD)/(PSEM) (NSR)
Aug 10, 2015 05:41PM Market Wrap: Buffett Lands 'Whale' of A Deal; Google Announces Major Restructuring; Twitter Gains on Insider Trades
Aug 10, 2015 09:33AM Pre-Open Stock Movers 08/10: (AQXP) (VLTC) (INO) (PCP) Higher; (SYN) (JD) (FCX) Lower (more...)
View More Recent Stories View Older Stories